Pulmonary candidiasis treated with 5-fluorocytosine.
D000935:Antifungal Agents / Q000627:therapeutic use*; D002176:Candida albicans; D002177:Candidiasis / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D003596:Cytosine / Q000627:therapeutic use*; D005260:Female; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D008172:Lung Diseases, Fungal / Q000188:drug therapy* / Q000276:immunology; D014777:Virus Diseases / Q000150:complications
D000935:Antifungal Agents; D003596:Cytosine; D005437:Flucytosine